Ignite Creation Date:
2024-05-06 @ 7:22 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02521051
Status:
UNKNOWN
Last Update Posted:
2019-11-26
First Post:
2015-07-20
Brief Title:
Phase III Trial of Alectinib and Bevacizumab in Patients With Advanced Anaplastic Lymphoma Kinase ALK-Positive Non-Small Cell Lung Cancer
Sponsor:
Organization:
Massachusetts General Hospital